Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics, Safety and Tolerability of ZL-1503 in Healthy Volunteers
NCT07658482Phase 1Not yet recruiting
- Sponsor
- Zai Lab
- Start
- Sep 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ZL-1503 (3 arms), sponsored by Zai Lab. Primary endpoints: Maximum plasma concentration, Time to maximum concentration and 8 more. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
ZL-1503
Beyond the preview
Go deeper on NCT07658482.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07658482.